Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.
Emilie Le RhunFelix Boakye OppongMaureen VanlanckerRoger StuppBurt NaborsOlivier ChinotWolfgang WickMatthias PreusserThierry GorliaMichael WellerPublished in: Neuro-oncology (2022)
The association of higher neutrophil counts at baseline with inferior PFS and OS requires further prospective evaluation. The link of therapy-induced lymphopenia to better outcome may guide the design for immunotherapy trials in newly diagnosed glioblastoma.